Speaker illustration

Doctor Steven Deitelzweig

Ochsner Clinic Foundation, New Orleans (United States of America)

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials

Thumbnail

Comparison of stroke and major bleeding risk of treatment with apixaban vs. rivaroxaban and dabigatran among elderly nonvalvular atrial fibrillation patients in the United States

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation

Thumbnail

Real-world comparison of major bleeding risk associated with direct oral anticoagulants or warfarin in patients with non-valvular atrial fibrillation: a systematic review and network meta-analysis.

Event: ESC CONGRESS 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment

Thumbnail

Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation II

Thumbnail

This platform is supported by

logo Novo Nordisk